Estrogen in the thyroid gland can upregulate VEGF levels, and it has been shown that increased intracellular ROS in thyroid cancer causes HIF-1α overexpression, and sustained and stable release of VEGF, but antioxidants N-acetylcysteine can eliminate these effects (42). Here, HIF1A is linked to thyroid gland carcinoma.